Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07421557
Brief Summary:
Occlutech AFR use allowed per FDA's Expanded Access program.
Detailed Description:
Occlutech AFR use allowed per FDA's Expanded Access program. Each individual request is sent for FDA approval and the site's IRB approval per regulations.
Study:
NCT07421557
Study Brief:
Protocol Section:
NCT07421557